Effect of Central Blockade of Mineralocorticoid Receptor, Angiotensin II Type 1 Receptor and Reactive Oxygen Species on Aldosterone/nacl‐induced Hypertension in Conscious Rats

Baojian Xue,Daniel Badaue-Passos,Yu-Ming Kang,Alan Kim Johnson,Meredith Hay
DOI: https://doi.org/10.1096/fasebj.21.5.a476-a
2007-01-01
Abstract:There is evidence of central nervous system involvement in the pathogenesis of aldosterone (Aldo) hypertension. The pressor effects of Aldo are mediated at least in part by the generation of reactive oxygen species (ROS) and involve an interaction with the renin-angiotensin system. The present study was performed to determine the effects of central blockade of mineralocorticoid receptor (MR), angiotensin II type 1 (AT1) receptor, or ROS on Aldo/NaCl-induced hypertension in male rats. Either peripheral (0.75 μg/h) or ICV (100 ng/h) infusion of Aldo combined with 1% NaCl as the sole source of drinking fluid induced a progressive increase in BP (98.8±2.2 to 122.4±2.3, 105.7±1.9 to 122.3±1.9 mmHg at wk 4, respectively). Central infusions of spironolactone (MR antagonist, 250 ng/h), or Irbesartan (AT1 receptor antagonist, 125 μg/d) blocked peripheral Aldo/NaCl-induced hypertension (106.6±0.8 to 112.1±0.7, 107.6±4.1 to 107.4±7.5 mmHg at wk 4, respectively). Moreover, central (but not peripheral, 109.5 to 130.6 mmHg at wk 4) infusions of the superoxide dismutase mimetic, tempol (200 nm/kg/min), prevented development of hypertension (107.3±2.5 to 111.5±3.4 mmHg at wk 4). These data indicate that central MR or AT1 receptors may mediate Aldo/NaCl-induced hypertension, and that central ROS are involved in the development of Aldo/NaCl-induced hypertension. (Support: NIH HL62261 & HL59676)
What problem does this paper attempt to address?